Prostate Cancer Is A Big Problem
2006 EU Estimates Of Incidence >340,000
2007 USA Statistics Of Incidence >230,000
Newly Diagnosed…Each Year!!!
Profoundly Different Thinking…
The company’s vision is to advance the pre-clinical and clinical
development in all major global markets to appropriate regulatory compliance.
Profound Medical Inc. (PMI) is commercialising a unique, minimally-invasive
approach for the treatment of prostate cancer.
May 16, 2013 Profound Medical Announces Initiation of TULSA Clinical Trial for Treatment of Localized Prostate Cancer; PMI initiates Transurethral Ultrasound Ablation (TULSA) clinical trial for novel, minimally invasive device for localized prostate cancer treatment